Search Results - "Koot, Bart G."

A multisociety Delphi consensus statement on new fatty liver disease nomenclature by Rinella, Mary E, Lazarus, Jeffrey V, Ratziu, Vlad, Francque, Sven M, Sanyal, Arun J, Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F, Anstee, Quentin M, Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D, Castro Narro, Graciela E, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R, Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D, Harrison, Stephen A, Kim, Seung Up, Koot, Bart G, Korenjak, Marko, Kowdley, Kris V, Lacaille, Florence, Loomba, Rohit, Mitchell-Thain, Robert, Morgan, Timothy R, Powell, Elisabeth E, Roden, Michael, Romero-Gómez, Manuel, Silva, Marcelo, Singh, Shivaram Prasad, Sookoian, Silvia C, Spearman, C Wendy, Tiniakos, Dina, Valenti, Luca, Vos, Miriam B, Wong, Vincent Wai-Sun, Xanthakos, Stavra, Yilmaz, Yusuf, Younossi, Zobair, Hobbs, Ansley, Villota-Rivas, Marcela, Newsome, Philip N

“…The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This…”
Get full text

Pediatric MASLD: current understanding and practical approach by Stroes, Anne-Sophie R., Vos, Miriam, Benninga, Marc A., Koot, Bart G. P.

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most prevalent chronic liver disease in children in industrialized countries mainly…”
Get full text

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity by Runge, Jurgen H., van Giessen, Jet, Draijer, Laura G., Deurloo, Eline E., Smets, Anne M. J. B., Benninga, Marc A., Koot, Bart G. P., Stoker, Jaap

“…Objectives To determine the diagnostic accuracy of controlled attenuation parameter (CAP) on FibroScan ® in detecting and grading steatosis in a screening…”
Get full text

Identification of human D lactate dehydrogenase deficiency by Monroe, Glen R., van Eerde, Albertien M., Tessadori, Federico, Duran, Karen J., Savelberg, Sanne M. C., van Alfen, Johanna C., Terhal, Paulien A., van der Crabben, Saskia N., Lichtenbelt, Klaske D., Fuchs, Sabine A., Gerrits, Johan, van Roosmalen, Markus J., van Gassen, Koen L., van Aalderen, Mirjam, Koot, Bart G., Oostendorp, Marlies, Duran, Marinus, Visser, Gepke, de Koning, Tom J., Calì, Francesco, Bosco, Paolo, Geleijns, Karin, de Sain-van der Velden, Monique G. M., Knoers, Nine V., Bakkers, Jeroen, Verhoeven-Duif, Nanda M., van Haaften, Gijs, Jans, Judith J.

“…Phenotypic and biochemical categorization of humans with detrimental variants can provide valuable information on gene function. We illustrate this with the…”
Get full text

The child’s perception on monitoring inflammatory bowel disease activity by van Wassenaer, Elsa A., van der Klift, Renée R., Staphorst, Mira S., van der Lee, Johanna H., Benninga, Marc A., Koot, Bart G. P.

“…To determine the perception of children with inflammatory bowel disease (IBD) regarding monitoring tests, we first compared the reported discomfort and patient…”
Get full text

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis by Deneau, Mark R., Mack, Cara, Mogul, Douglas, Perito, Emily R., Valentino, Pamela L., Amir, Achiya Z., DiGuglielmo, Matthew, Draijer, Laura G., El‐Matary, Wael, Furuya, Katryn N., Gupta, Nitika, Hochberg, Jessica T., Horslen, Simon, Jensen, M. Kyle, Jonas, Maureen M., Kerkar, Nanda, Koot, Bart G.P., Laborda, Trevor J., Lee, Christine K., Loomes, Kathleen M., Martinez, Mercedes, Miethke, Alexander, Miloh, Tamir, Mohammad, Saeed, Ovchinsky, Nadia, Rao, Girish, Ricciuto, Amanda, Sathya, Pushpa, Schwarz, Kathleen B., Shah, Uzma, Singh, Ruchi, Vitola, Bernadette, Zizzo, Andréanne, Guthery, Stephen L.

“…Background and Aims Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a…”
Get full text

Non-radiologist-performed abdominal point-of-care ultrasonography in paediatrics — a scoping review by van Wassenaer, Elsa A., Daams, Joost G., Benninga, Marc A., Rosendahl, Karen, Koot, Bart G. P., Stafrace, Samuel, Arthurs, Owen J., van Rijn, Rick R.

“…Background Historically, US in the paediatric setting has mostly been the domain of radiologists. However, in the last decade, there has been an uptake of…”
Get full text

Fool me once… treatment exposure to achieve remission in pediatric IBD by Van Limbergen, Johan E., Koot, Bart G. P., de Winter, J. Peter

Get full text

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease by Hoekman, Daniël R., Diederen, Kay, Koot, Bart G. P., Tabbers, Merit M., Kindermann, Angelika, Benninga, Marc A.

“…In adult inflammatory bowel disease (IBD) patients, there is a strong discrepancy between symptoms and biomarkers of inflammation. Data on pediatric IBD…”
Get full text

Bowel ultrasound measurements in healthy children — systematic review and meta-analysis by van Wassenaer, Elsa A., de Voogd, Floris A. E., van Rijn, Rick R., van der Lee, Johanna H., Tabbers, Merit M., van Etten-Jamaludin, Faridi S., Kindermann, Angelika, de Meij, Tim G. J., Gecse, K. B., D’Haens, Geert R., Benninga, Marc A., Koot, Bart G. P.

“…Background Ultrasound (US) is a noninvasive method of assessing the bowel that can be used to screen for bowel pathology, such as Inflammatory Bowel Disease,…”
Get full text

US Cannot Be Used to Predict the Presence or Severity of Hepatic Steatosis in Severely Obese Adolescents by BOHTE, Anneloes E, KOOT, Bart G. P, VAN DER BAAN-SLOOTWEG, Olga H, PELS RIJCKEN, Tammo H, VAN WERVEN, Jochem R, BIPAT, Shandra, NEDERVEEN, Aart J, JANSEN, Peter L. M, BENNINGA, Marc A, STOKER, Jaap

“…To evaluate the diagnostic accuracy of ultrasonography (US) for the assessment of hepatic steatosis in severely obese adolescents, with proton magnetic…”
Get full text

Cholic acid therapy in Zellweger spectrum disorders by Berendse, Kevin, Klouwer, Femke C. C., Koot, Bart G. P., Kemper, Elles M., Ferdinandusse, Sacha, Koelfat, Kiran V. K., Lenicek, Martin, Schaap, Frank G., Waterham, Hans R., Vaz, Frédéric M., Engelen, Marc, Jansen, Peter L. M., Wanders, Ronald J. A., Poll-The, Bwee Tien

“…Introduction Zellweger spectrum disorders (ZSDs) are characterized by a failure in peroxisome formation, caused by autosomal recessive mutations in different…”
Get full text

Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms by Hudert, Christian A., Adams, Leon A., Alisi, Anna, Anstee, Quentin M., Crudele, Annalisa, Draijer, Laura G., Furse, Samuel, Hengstler, Jan G., Jenkins, Benjamin, Karnebeek, Kylie, Kelly, Deirdre A., Koot, Bart G., Koulman, Albert, Meierhofer, David, Melton, Phillip E., Mori, Trevor A., Snowden, Stuart G., Mourik, Indra, Vreugdenhil, Anita, Wiegand, Susanna, Mann, Jake P.

“…Genome‐wide association studies in adults have identified variants in hydroxysteroid 17‐beta dehydrogenase 13 (HSD17B13) and mitochondrial amidoxime reducing…”
Get full text

Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis by El-Matary, Wael, Guthery, Stephen L., Amir, Achiya Z., DiGuglielmo, Matthew, Draijer, Laura G., Furuya, Katryn N., Gupta, Nitika, Hochberg, Jessica T., Horslen, Simon, Kerkar, Nanda, Koot, Bart G.P., Laborda, Trevor J., Loomes, Kathleen M., Mack, Cara, Martinez, Mercedes, Miethke, Alexander, Miloh, Tamir, Mogul, Douglas, Mohammed, Saeed, Moroz, Stacy, Ovchinsky, Nadia, Perito, Emily R., Rao, Girish, Ricciuto, Amanda, Sathya, Pushpa, Schwarz, Kathleen B., Shah, Uzma, Singh, Ruchi, Soufi, Nisreen, Valentino, Pamela L., Zizzo, Andréanne, Deneau, Mark R.

“…Inflammatory bowel disease (IBD), especially when associated with primary sclerosing cholangitis (PSC), is a risk factor for developing colorectal cancer…”
Get full text

Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement by Koot, Bart G P, van der Baan-Slootweg, Olga H, Tamminga-Smeulders, Christine L J, Rijcken, Tammo H Pels, Korevaar, Joke C, van Aalderen, Wim M, Jansen, Peter L M, Benninga, Marc A

“…Background Non-alcoholic fatty liver disease (NAFLD) has a high prevalence in obese children. Lifestyle intervention is the primary treatment for NAFLD…”
Get full text

The cholic acid extension study in Zellweger spectrum disorders: Results and implications for therapy by Klouwer, Femke C. C., Koot, Bart G. P., Berendse, Kevin, Kemper, Elles M., Ferdinandusse, Sacha, Koelfat, Kiran V. K., Lenicek, Martin, Vaz, Frédéric M., Engelen, Marc, Jansen, Peter L. M., Wanders, Ronald J. A., Waterham, Hans R., Schaap, Frank G., Poll‐The, Bwee Tien

“…Introduction Currently, no therapies are available for Zellweger spectrum disorders (ZSDs), a group of genetic metabolic disorders characterised by a…”
Get full text

A multisociety Delphi consensus statement on new fatty liver disease nomenclature by Rinella, Mary E, Lazarus, Jeffrey V, Ratziu, Vlad, Francque, Sven M, Sanyal, Arun J, Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F, Anstee, Quentin M, Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D, Castro Narro, Graciela E, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R, Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D, Harrison, Stephen A, Kim, Seung Up, Koot, Bart G, Korenjak, Marko, Kowdley, Kris V, Lacaille, Florence, Loomba, Rohit, Mitchell-Thain, Robert, Morgan, Timothy R, Powell, Elisabeth E, Roden, Michael, Romero-Gómez, Manuel, Silva, Marcelo, Singh, Shivaram Prasad, Sookoian, Silvia C, Spearman, C Wendy, Tiniakos, Dina, Valenti, Luca, Vos, Miriam B, Wong, Vincent Wai-Sun, Xanthakos, Stavra, Yilmaz, Yusuf, Younossi, Zobair, Hobbs, Ansley, Villota-Rivas, Marcela, Newsome, Philip N

“…The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This…”
Get full text

Does Giardia lamblia Cause Villous Atrophy in Children?: A Retrospective Cohort Study of the Histological Abnormalities in Giardiasis by Koot, Bart GP, Kate, Fiebo JW, Juffrie, Mohammad, Rosalina, Ina, Taminiau, Jan JAM, Benninga, Marc A

“…ABSTRACT Objective: To determine the prevalence and type of histological abnormalities in duodenal mucosa associated with Giardia lamblia in children who…”
Get full text

Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors by Mulder, Renée L, Kremer, Leontien C.M, Koot, Bart G.P, Benninga, Marc A, Knijnenburg, Sebastiaan L, van der Pal, Helena J.H, Koning, Caro C.E, Oldenburger, Foppe, Wilde, James C.H, Taminiau, Jan A.J.M, Caron, Huib N, van Dalen, Elvira C

“…Abstract Background Childhood cancer survivors (CCS) are a growing group of young individuals with a high risk of morbidity and mortality. We evaluated the…”
Get full text

A multisociety Delphi consensus statement on new fatty liver disease nomenclature by Rinella, Mary E, Lazarus, Jeffrey V, Ratziu, Vlad, Francque, Sven M, Sanyal, Arun J, Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F, Anstee, Quentin M, Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D, Narro, Graciela E Castro, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R, Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D, Harrison, Stephen A, Kim, Seung Up, Koot, Bart G, Korenjak, Marko, Kowdley, Kris V, Lacaille, Florence, Loomba, Rohit, Mitchell-Thain, Robert, Morgan, Timothy R, Powell, Elisabeth E, Roden, Michael, Romero-Gómez, Manuel, Silva, Marcelo, Singh, Shivaram Prasad, Sookoian, Silvia C, Spearman, C Wendy, Tiniakos, Dina, Valenti, Luca, Vos, Miriam B, Wong, Vincent Wai-Sun, Xanthakos, Stavra, Yilmaz, Yusuf, Younossi, Zobair, Hobbs, Ansley, Villota-Rivas, Marcela, Newsome, Philip N

“…The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This…”
Get full text